Skip to content

Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting

Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting-A Cross-sectional Study of Adult Asthma Patients in Japan

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02640742
Acronym
ACQUIRE-2
Enrollment
1232
Registered
2015-12-29
Start date
2015-12-18
Completion date
2016-06-01
Last updated
2017-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

This study aims to evaluate the asthma control status, asthma symptoms (severity, frequency, and limitations on activities, etc.), QOL, and use of drugs for asthma attack in adult asthma patients.

Detailed description

Rationale for this Non-Interventional Study According to the Japanese Asthma Prevention and Management Guideline 2015 (Japan guideline (JGL) 2015), the goal in the management and treatment of asthma is to be able to lead a life like a healthy individual. In order to achieve this therapeutic goal, the achievement of well-controlled state based on the asthma control status is considered to be a clinical goal. However, there are few studies in which the asthma control status is accurately surveyed in a real life setting in adult asthma patients receiving continued treatment from physician in Japan and the actual situation is unknown. By understanding the status of asthma control in asthma patients in a real life setting, the clinical issues could be clarified. Therefore, such information would contribute to appropriate treatment of asthma. Thus, we planned this study to evaluate the asthma control status, asthma symptoms (severity, frequency, and limitations on activities, etc.), Quality of line (QOL), and use of drugs for asthma attack in the study population in a real life setting by recruiting patients through medical institutions providing continued care for asthma patients. Objectives of this Non-Interventional Study 1. Primary objective To assess the proportion of adult asthma patients receiving continued treatment from physician in Japan in each asthma control status defined by JGL 2015 (poorly-controlled, insufficiently-controlled, and well-controlled). 2. Secondary objectives To evaluate asthma symptoms (intensity, frequency, and limitations on activities, etc.), QOL, use of drugs for asthma attack, and emotional feelings in the study population; and to investigate the effects of demographic characteristics and pathologic properties of each patient on the status of asthma control, asthma symptoms, QOL, use of drugs for asthma attack, and emotional feelings.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Provided written consent before starting any procedure specified in the study protocol * Aged 20 years or older at the time of providing the consent * Receiving treatment for asthma as an outpatient at the time of providing the consent * Physician definitive diagnosis of asthma at least 1 year before providing the consent * Started to receive treatment with at least 1 of the following asthma drugs at least 1 year before providing the consent

Exclusion criteria

* Enrolled in this study in the past * Assessed by the Investigator to require additional treatment due to worsening of asthma symptoms at the time of providing the consentEnrolled in this study in the past * Scheduled to be hospitalized within 2 weeks after providing the consent due to asthma or any other disease * Participating in another interventional study such as a clinical study at the time of providing the consent * Considered by the Investigator as not appropriate for enrollment in this study due to inability to adhere to the procedures, limitations, and requirements of this study including answering and returning the questionnaires, etc.

Design outcomes

Primary

MeasureTime frameDescription
The primary variable is status of asthma control in each patientDay1 to Day7Status of asthma control will be evaluated based on the patient diary and information in the clinical report form (CRF). Of the 6 items of Japanese guideline(JGL) 2015, the following 4 items will be used as indicators for evaluation of asthma control status: asthma symptoms (daytime and nighttime), use of a drug for asthma attack, limitation on activities including exercise, exacerbation (unscheduled visit, emergency room visit, and hospitalization). Status of asthma control in each patient (well controlled, insufficiently controlled, and poorly-controlled ) will be evaluated according to the evaluation criteria in JGL 2015.

Secondary

MeasureTime frameDescription
Use of drugs for the treatment of asthmaBaselineTo be evaluated from case report form.
Asthma control during the past 1 weekBaselineTo be evaluated by Asthma Control Questionare-5 (Japanese Version).
Asthma symptomsBaselineTo be evaluated based on Patient diary.
QOLBaselineTo be evaluated by Mini Asthma Quality of Life Questionnaire (Japanese Version)
Use of drugs for asthma attack and emotional feelingsBaselineTo be evaluated based on Patients' Questionnaire
Asthma control status during the past 1 monthBaselineTo be evaluated based on Patients' Questionnaire, case report form.

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026